14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $34.24 $40.91 Tuesday, 23rd Apr 2024 COLL stock ended at $35.94. This is 3.45% more than the trading day before Monday, 22nd Apr 2024. During the day the stock fluctuated 4.53% from a day low at $34.92 to a day high of $36.51.
90 days $31.34 $40.91
52 weeks $20.84 $40.91

Historical Collegium Pharmaceutical prices

Date Open High Low Close Volume
Apr 23, 2024 $35.00 $36.51 $34.92 $35.94 544 824
Apr 22, 2024 $34.93 $35.30 $34.55 $34.74 361 737
Apr 19, 2024 $34.65 $35.34 $34.24 $34.84 316 197
Apr 18, 2024 $35.47 $35.47 $34.69 $34.77 193 412
Apr 17, 2024 $35.47 $35.73 $34.83 $35.45 248 573
Apr 16, 2024 $35.03 $35.81 $34.75 $35.40 316 117
Apr 15, 2024 $35.67 $35.83 $35.12 $35.14 356 378
Apr 12, 2024 $36.51 $36.51 $35.47 $35.71 366 280
Apr 11, 2024 $37.97 $37.97 $35.72 $36.39 450 215
Apr 10, 2024 $38.29 $38.89 $37.95 $37.99 303 143
Apr 09, 2024 $39.37 $39.53 $38.41 $38.79 200 711
Apr 08, 2024 $39.67 $40.02 $38.89 $39.42 229 407
Apr 05, 2024 $39.23 $40.24 $39.05 $39.99 377 438
Apr 04, 2024 $39.60 $40.49 $39.18 $39.30 357 977
Apr 03, 2024 $38.25 $39.46 $38.24 $39.45 253 683
Apr 02, 2024 $38.35 $39.03 $38.12 $38.40 335 646
Apr 01, 2024 $38.54 $38.97 $37.63 $38.88 351 385
Mar 28, 2024 $40.87 $40.87 $38.59 $38.82 613 299
Mar 27, 2024 $40.10 $40.91 $39.97 $40.91 349 937
Mar 26, 2024 $40.32 $40.32 $39.44 $39.93 328 053
Mar 25, 2024 $39.78 $40.59 $39.55 $40.16 269 068
Mar 22, 2024 $39.56 $39.96 $39.13 $39.72 288 178
Mar 21, 2024 $38.98 $39.80 $38.47 $39.66 564 846
Mar 20, 2024 $37.61 $38.88 $37.29 $38.79 519 232
Mar 19, 2024 $39.37 $39.37 $37.74 $37.96 835 339
Click to get the best stock tips daily for free!

About Collegium Pharmaceutical

Collegium Pharmaceutical Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ER for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatm... COLL Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT